You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Sickle ß0-Thalassemia

Showing 1 - 25 of 1,158
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Sickle Cell Anemia, Thalassemia Trial in United States (L-glutamine, Placebo)

Completed
Has Results
  • Sickle Cell Anemia
  • Thalassemia
  • Bellflower, California
  • +4 more
Jan 11, 2021

Sickle Cell Anemia, Thalassemia Trial in Torrance (L-Glutamine, Placebo)

Terminated
Has Results
  • Sickle Cell Anemia
  • Thalassemia
  • Torrance, California
    LA Biomed at Harbor-UCLA Medical Center
Feb 1, 2021

Sickle Cell Disease, Hb-SS Disease, Hemoglobin S Trial run by the National Heart, Lung, and Blood Institute (NHLBI)

Not yet recruiting
  • Sickle Cell Disease
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jun 21, 2023

Sickle Cell Disease, Sickle Cell Trait, Beta-Thalassemia Trial (High performance liquid chromatography, Automated sickling test,

Not yet recruiting
  • Sickle Cell Disease
  • +4 more
  • High performance liquid chromatography
  • +5 more
  • (no location specified)
Aug 17, 2022

Sickle Cell Anemia, Sickle ß0-Thalassemia Trial in United States (L-glutamine, Placebo)

Completed
Has Results
  • Sickle Cell Anemia
  • Sickle ß0-Thalassemia
  • Mobile, Alabama
  • +30 more
Aug 17, 2020

Sickle Cell Disease, Thalassemia, Beta, Thalassemia Trial in United States (Fludarabine, Cyclophosphamide, Tacrolimus)

Recruiting
  • Sickle Cell Disease
  • +2 more
  • Basking Ridge, New Jersey
  • +5 more
Feb 17, 2023

Sickle Cell Disease Trial in United Kingdom, United States (IMR-687, Placebo)

Completed
Has Results
  • Sickle Cell Disease
  • Oakland, California
  • +12 more
Mar 22, 2022

Sickle Cell Disease, Hemoglobin SC Trial in Houston (Busulfan, Campath 1H, Cyclophosphamide and MESNA)

Terminated
Has Results
  • Sickle Cell Disease
  • Hemoglobin SC
  • Houston, Texas
  • +1 more
Jul 16, 2020

Sickle Cell Anemia, Hemoglobinopathy, Thalassemia Trial in Houston (FLUDARABINE, CAMPATH-IH, Total Body Irradiation)

Terminated
  • Sickle Cell Anemia
  • +2 more
  • Houston, Texas
  • +1 more
Jan 15, 2020

Sickle Cell Anemia, Hemoglobinopathy, Thalassemia Trial in Houston (Campath -1H, Dilantin, Busulfan)

Terminated
  • Sickle Cell Anemia
  • +2 more
  • Campath -1H
  • +3 more
  • Houston, Texas
  • +1 more
Jan 15, 2020

Sickle Cell Disease Trial in United Kingdom, United States (IMR-687)

Active, not recruiting
  • Sickle Cell Disease
  • Farmington, Connecticut
  • +6 more
Mar 2, 2022

Sickle Cell Disease, Sickle-Beta Zero Thalassemia Trial in Brooklyn (SCD-101)

Recruiting
  • Sickle Cell Disease
  • Sickle-Beta Zero Thalassemia
  • Brooklyn, New York
    King's County Hospital
Feb 19, 2021

Sickle Cell Disease, Sickle Cell-Beta0-Thalassemia Trial (Isoquercetin)

Withdrawn
  • Sickle Cell Disease
  • Sickle Cell-Beta0-Thalassemia
  • (no location specified)
Jan 7, 2021

Pumilio1 Expression, Sickle Cell Anemia, ß-thalassemia

Not yet recruiting
  • Sickle Cell Disease, Beta Thalassemia Intermedia
  • RNA Binding Protein Pumilio1 (PUM1) Expression by reverse transcriptase quantatative PCR
  • (no location specified)
May 30, 2023

Sickle Cell Disease, Sickle Cell Disorder, Hemoglobinopathies Trial in Duarte (Cyclophosphamide, Pentostatin, Rabbit

Recruiting
  • Sickle Cell Disease
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Jul 6, 2022

Transfusion-dependent Thalassemia Trial in Dhaka (Thalidomide Capsules, Placebo)

Recruiting
  • Transfusion-dependent Thalassemia
  • Thalidomide Capsules
  • Placebo
  • Dhaka, Bangladesh
    Bangabandhu Sheikh Mujib Medical University
Oct 18, 2023

Sickle Cell Disease and Genomic and Gene Therapy Needs of

Recruiting
  • Sickle Cell Disease
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Apr 4, 2022

    Sickle Cell Anemia, Sickle Cell-Beta0-Thalassemia Trial in Chapel Hill (rivaroxaban, )

    Completed
    Has Results
    • Sickle Cell Anemia
    • Sickle Cell-Beta0-Thalassemia
    • Chapel Hill, North Carolina
      University of North Carolina - Chapel Hill
    Apr 9, 2020

    Hemoglobinopathies, Thalassemia, Sickle Cell Disease Trial in Banha (Hemoglobinopathy Nursing Program)

    Completed
    • Hemoglobinopathies
    • +3 more
    • Hemoglobinopathy Nursing Program
    • Banhā, Other, Egypt
      Benha University
    May 21, 2022

    Sickle Cell Disease, Dyslipidemia, Complication Trial in Pointe-à-Pitre, Le Lamentin (HDL2)

    Recruiting
    • Sickle Cell Disease
    • +2 more
    • HDL2
    • Pointe-à-Pitre, Guadeloupe, France
    • +1 more
    Mar 21, 2023

    Sickle Cell Anemia, Beta Thalassemia Trial run by the NHLBI (radiation, drug, biological)

    Recruiting
    • Sickle Cell Anemia
    • Beta Thalassemia
    • TBI
    • +6 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 26, 2023

    Cardiovascular Complications of Sickle Cell Disease

    Completed
    Has Results
    • Sickle Cell Disease
    • MRI, Transthoracic Echocardiography, tonometry, EKG
    • Chicago, Illinois
      University of Chicago Medical Center
    Feb 8, 2022

    VO2max & HRQoL in Children With Sickle Cell Disease

    Completed
    • Sickle Cell
    • Children
      • Montpellier, Occitanie, France
        Pediatric and Congenital Cardiology Department, Arnaud De Villen
      Aug 16, 2023

      ß-thalassemia Trial in Shenzhen (ß-globin restored autologous hematopoietic stem cells)

      Recruiting
      • β-thalassemia
      • β-globin restored autologous hematopoietic stem cells
      • Shenzhen, Guangdong, China
        Shenzhen University General Hospital
      May 8, 2023

      ß-thalassemia Trial in Shenzhen (ß-globin restored autologous hematopoietic stem cells)

      Recruiting
      • β-thalassemia
      • β-globin restored autologous hematopoietic stem cells
      • Shenzhen, Guangdong, China
        Shenzhen Children's Hospital
      Feb 24, 2023